RUSSO, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 4.161
EU - Europa 2.671
AS - Asia 2.537
SA - Sud America 538
AF - Africa 465
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 10.402
Nazione #
US - Stati Uniti d'America 4.025
SG - Singapore 1.184
RU - Federazione Russa 901
IT - Italia 751
CN - Cina 710
BR - Brasile 436
CI - Costa d'Avorio 264
IE - Irlanda 257
VN - Vietnam 215
DE - Germania 153
KR - Corea 143
FR - Francia 139
CA - Canada 100
FI - Finlandia 88
UA - Ucraina 74
NG - Nigeria 64
GB - Regno Unito 63
BD - Bangladesh 53
AT - Austria 49
NL - Olanda 48
SN - Senegal 42
TR - Turchia 41
AR - Argentina 36
KE - Kenya 33
IN - India 32
SE - Svezia 29
ZA - Sudafrica 24
AU - Australia 21
PL - Polonia 19
BE - Belgio 18
CZ - Repubblica Ceca 18
PK - Pakistan 17
VE - Venezuela 17
JP - Giappone 16
IQ - Iraq 15
MX - Messico 15
BJ - Benin 14
EC - Ecuador 14
CO - Colombia 12
HK - Hong Kong 12
ID - Indonesia 12
IR - Iran 12
UZ - Uzbekistan 11
ES - Italia 9
PT - Portogallo 9
CH - Svizzera 8
PY - Paraguay 8
AE - Emirati Arabi Uniti 7
GR - Grecia 7
TW - Taiwan 7
LT - Lituania 6
BG - Bulgaria 5
CL - Cile 5
EG - Egitto 5
KG - Kirghizistan 5
KZ - Kazakistan 5
LB - Libano 5
NP - Nepal 5
NZ - Nuova Zelanda 5
SA - Arabia Saudita 5
TN - Tunisia 5
AZ - Azerbaigian 4
CR - Costa Rica 4
DZ - Algeria 4
HN - Honduras 4
HU - Ungheria 4
MA - Marocco 4
SV - El Salvador 4
UY - Uruguay 4
ET - Etiopia 3
IL - Israele 3
JM - Giamaica 3
JO - Giordania 3
OM - Oman 3
PE - Perù 3
PH - Filippine 3
BO - Bolivia 2
BY - Bielorussia 2
HR - Croazia 2
LV - Lettonia 2
MY - Malesia 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
RO - Romania 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AQ - Antartide 1
BB - Barbados 1
DK - Danimarca 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GF - Guiana Francese 1
GT - Guatemala 1
MM - Myanmar 1
MT - Malta 1
Totale 10.398
Città #
Singapore 734
Dallas 689
Santa Clara 539
Chandler 435
Moscow 392
San Jose 319
Abidjan 264
Dublin 246
Ashburn 211
Chicago 184
Catania 179
Hefei 172
Seoul 142
Houston 114
Beijing 111
Boardman 105
Los Angeles 99
Lauterbourg 78
Ho Chi Minh City 70
Jacksonville 69
Civitanova Marche 63
Nuremberg 63
Cambridge 61
Lawrence 61
Council Bluffs 57
Andover 55
Hanoi 52
Helsinki 45
New York 43
Dakar 42
Nanjing 39
Lappeenranta 38
Rome 36
Des Moines 34
São Paulo 32
Toronto 32
Vienna 31
Abuja 28
Bremen 27
Buffalo 27
Lagos 26
Wilmington 23
Munich 22
Montreal 20
Pozzallo 19
Amsterdam 18
Dong Ket 18
Falls Church 18
Kayseri 18
Ottawa 18
Warsaw 18
Shanghai 17
Brno 16
Brussels 16
Columbus 16
Denver 16
Acireale 15
San Giovanni la Punta 15
The Dalles 15
Cotonou 14
Nanchang 14
Rio de Janeiro 14
Atlanta 13
Messina 13
Naples 13
Saint Petersburg 13
Turin 13
Chennai 12
Johannesburg 12
Orem 12
Poplar 12
Tokyo 12
Belo Horizonte 11
Boston 11
Hong Kong 11
Mascalucia 11
Melbourne 11
Nairobi 11
Seattle 11
Grafing 10
Milan 10
Palermo 10
Phoenix 10
Port Harcourt 10
Salvador 10
Stockholm 10
Tianjin 10
Avola 9
Brooklyn 9
Da Nang 9
Haiphong 9
Pedara 9
Tehran 9
Campinas 8
Cape Town 8
Florence 8
London 8
Redondo Beach 8
San Mateo 8
Zhengzhou 8
Totale 6.796
Nome #
((2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist 321
A Credibility Assessment Plan for an In Silico Model that Predicts the Dose-Response Relationship of New Tuberculosis Treatments 196
2DIs: a SBML compliant web platform for the design and modeling of immune system interactions 194
A MapReduce Based Tool for the Analysis and Discovery of Novel Therapeutic Targets 190
Agent based modeling of relapsing multiple sclerosis: A possible approach to predict treatment outcome 179
Computational modelling in melanoma for novel drug discovery 178
Agent based modeling of the immune system: NetLogo, a promising framework 172
Computational modeling of immunologic response to immune checkpoint inhibitors in COVID-19 patients with and without cancer 170
Agent based modeling of the effects of potential treatments over the blood-brain barrier in multiple sclerosis 167
A multi-step and multi-scale bioinformatic protocol to investigate potential SARS-CoV-2 vaccine targets 162
R- ed S-LP2: sintesi, molecular docking e valutazione farmacologica 159
A MapReduce tool for in-depth analysis of KEGG pathways: identification and visualization of therapeutic target candidates 159
Computational modeling of PI3K/AKT and MAPK signaling pathways in melanoma cancer 158
Boosting multiple sclerosis lesion segmentation through attention mechanism 157
A computational model to predict the immune system activation by citrus derived vaccine adjuvants 156
Advancing PFAS risk assessment: Integrative approaches using agent-based modelling and physiologically-based kinetic for environmental and health safety 154
An agent based modeling approach for the analysis of tuberculosis - Immune system dynamics 154
Gene Silencing of Transferrin-1 Receptor as a Potential Therapeutic Target for Human Follicular and Anaplastic Thyroid Cancer 149
The Potential of Computational Modeling to Predict Disease Course and Treatment Response in Patients with Relapsing Multiple Sclerosis 149
Gene expression and pathway bioinformatics analysis detect a potential predictive value of MAP3K8 in thyroid cancer progression 145
PEAK: A Clever Python Tool for Exploratory, Regression, and Classification Data. A Case Study for COVID-19 141
Combining agent based-models and virtual screening techniques to predict the best citrus-derived vaccine adjuvants against human papilloma virus 140
EpiMethEx: a tool for large-scale integrated analysis in methylation hotspots linked to genetic regulation 138
In silico clinical trials: concepts and early adoptions 136
Beyond the state of the art of reverse vaccinology: predicting vaccine efficacy with the universal immune system simulator for influenza 132
Enhancing Multiple Sclerosis Lesion Segmentation in Multimodal MRI Scans with Diffusion Models 131
DNA methylation and gene expression in melanoma: A large-scale integrated analysis 130
Predicting the artificial immunity induced by RUTI® vaccine against tuberculosis using universal immune system simulator (UISS) 129
BIOESOnet: A Tool for the Generation of Personalized Human Metabolic Pathways from 23andMe Exome Data 127
Combining Parallel Genetic Algorithms and Machine Learning to Improve the Research of Optimal Vaccination Protocols 126
In silico design of recombinant multi-epitope vaccine against influenza A virus 125
Computational modeling reveals MAP3K8 as mediator of resistance to vemurafenib in thyroid cancer stem cells 122
Computational identification of differentially-expressed genes as suggested novel COVID-19 biomarkers: A bioinformatics analysis of expression profiles 121
Moving forward through the in silico modeling of tuberculosis: a further step with UISS-TB 120
A multi-step and multi-scale bioinformatic approach to investigate potential source of cross-reactive immunity against SARS-CoV-2 UK variant 118
MSLesSeg: baseline and benchmarking of a new Multiple Sclerosis Lesion Segmentation dataset 116
Design and optimization of PEGylated nanoparticles intended for Berberine Chloride delivery 116
Model verification tools: a computational framework for verification assessment of mechanistic agent-based models 114
Evaluation of the efficacy of RUTI and ID93/GLA-SE vaccines in tuberculosis treatment: in silico trial through UISS-TB simulator 113
Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review) 113
Computational models to predict disease course and treatment response in multiple sclerosis 111
Reverse Vaccinology for Influenza A Virus: From Genome Sequencing to Vaccine Design 105
Credibility of In Silico Trial Technologies - A Theoretical Framing 105
GPU accelerated analysis of treg-teff cross regulation in relapsing-remitting multiple sclerosis 103
Genetic Algorithm-Based Prediction of Emerging SARS-CoV-2 Variants: A Computational Biology Perspective 102
Cutaneous Leishmaniasis: discovering new effective therapies using the Universal Immune System Simulator 102
Toward computational modelling on immune system function 102
Modeling Cutaneous Leishmaniasis: Insights into M1/M2 Macrophage Dynamics Using the Universal Immune System Simulator 101
PETAL: A Python tool for deep analysis of biological pathways 101
Computational modelling and simulation for immunotoxicity prediction induced by skin sensitisers 100
Computational modeling of the expansion of human cord blood CD133+ hematopoietic stem/progenitor cells with different cytokine combinations 99
In silico evaluation of daclizumab and vitamin D effects in multiple sclerosis using agent based models 97
Introducing scale factor adjustments on agent-based simulations of the immune system 96
Using Continuous Petri Nets to predict the impact of microRNA analysis in PI3K/Akt and MAPK Signaling Pathways 95
How can we accelerate COVID-19 vaccine discovery? 95
Moving forward through the in silico modeling of multiple sclerosis: Treatment layer implementation and validation 94
Modeling biology spanning different scales: An open challenge 93
Generation of digital patients for the simulation of tuberculosis with UISS-TB 93
The combination of artificial intelligence and systems biology for intelligent vaccine design 89
Text mining and word embedding for classification of decision making variables in breast cancer surgery 88
Toward a Regulatory Pathway for the Use of in Silico Trials in The Ce Marking of Medical Devices 88
Uncertainty quantification and sensitivity analysis for in silico trial platform: A preliminary application on UISS-MS 87
Optimization and analisys of vaccination schedules using simulated annealing and agent based models 86
Computational immunogenetics 85
ODEs approaches in modeling fibrosis. Comment on "Towards a unified approach in the modeling of fibrosis: A review with research perspectives" by Martine Ben Amar and Carlo Bianca 85
Computational modelling approaches to vaccinology 83
Translatability and transferability of in silico models: Context of use switching to predict the effects of environmental chemicals on the immune system 81
Pioneering bioinformatics with agent-based modelling: an innovative protocol to accurately forecast skin or respiratory allergic reactions to chemical sensitizers 81
Predictive Modelling of Allergic Responses to Chemical Sensitizers: Distinguishing Skin and Respiratory Reactions 80
Modeling and Simulation of anakinra effects on severe COVID19 Patients 78
Universal Immune System Simulator Analysis: The Impact of the Variable Approach Technique® on Enhancing Immune Defense Against infectious diseases 77
A Comparative Evaluation of Diffusion Based Networks for Multiple Sclerosis Lesion Segmentation 77
Quality by design tools reducing the gap from bench to bedside for nanomedicine 75
Comment on “A decade of thermostatted kinetic theory models for complex active matter living systems” by Carlo Bianca 74
Machine Learning techniques application to predict the quality of life degree in breast cancer patients 74
Genetic algorithm application for the prediction of potential SARS-CoV-2 new variant of concern 73
A Head-to-Head Evaluation of a Novel Universal Influenza Vaccine Against Current Formulation: Implications for Future Immunization Strategies 71
Modeling PI3K/PDK1/Akt and MAPK Signaling Pathways using Continuous Petri Nets 71
In silico trial to test COVID-19 candidate vaccines: a case study with UISS platform 71
Possible Contexts of Use for In Silico trials methodologies: a consensus- based review 71
Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility 70
Exploiting Stochastic Petri Net formalism to capture the Relapsing Remitting Multiple Sclerosis variability under Daclizumab administration 69
Generation of digital patients for the simulation of tuberculosis with UISS-TB 69
Novel computational strategies for the identification of new therapeutic targets in melanoma and thyroid cancer. 68
UISS-GPU: Accelerated In-Silico Tuberculosis Vaccine Trials Using FLAME GPU 67
In silico clinical trials for relapsing-remitting multiple sclerosis with MS TreatSim 65
Computational modeling approach to suggest possible therapeutic interventions in spinal muscular atrophy 65
Model Credibility 64
Modeling, simulation and prediction of protein structures for the design of oncolytic viruses 60
Evaluation of word embedding models to extract and predict surgical data in breast cancer 58
In vitro approaches to investigate the effect of chemicals on antibody production: the case study of PFASs 57
Model Development 56
Verification of an agent-based disease model of human Mycobacterium tuberculosis infection 55
Toward computational modelling on immune system function 52
Exploring SARS-CoV-2 spike protein mutations through genetic algorithm-driven structural modeling 50
Breaking the Cycle: Advancements in Universal Influenza Vaccine Design 48
Computational modeling of ATM signaling: a predictive framework for drug repurposing in ataxia-telangiectasia 25
In-silico epitope-based vaccines design: progress, challenges and the road ahead 22
A computational framework for optimizing mRNA vaccine delivery via AI-guided nanoparticle design and in silico gene expression profiling 21
When Bioinformatics Meets Agent-Based Modeling: An Evolving Paradigm for Complex Biological Systems 21
Totale 10.578
Categoria #
all - tutte 33.470
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.470


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202131 0 0 0 0 0 0 0 0 0 0 0 31
2021/2022479 48 57 4 13 84 9 62 26 35 20 14 107
2022/20231.111 72 81 23 163 98 173 7 178 217 14 39 46
2023/2024816 32 177 42 21 19 126 22 75 8 111 111 72
2024/20252.328 62 307 128 165 462 297 267 65 117 176 137 145
2025/20265.183 282 345 847 307 652 1.145 470 124 326 361 203 121
Totale 10.651